Published in Blood on June 01, 1987
Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells. J Exp Med (1992) 1.81
Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes. Proc Natl Acad Sci U S A (1989) 1.71
Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. Proc Natl Acad Sci U S A (1991) 1.25
Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. EMBO J (1996) 1.05
Central nervous system involvement at first relapse in patients with acute myeloid leukemia. Haematologica (2011) 0.95
Induction of acute lymphocytic leukemia differentiation by maintenance therapy. Leukemia (2007) 0.80
Combination toxicity of etoposide (VP-16) and photosensitisation with a water-soluble aluminium phthalocyanine in K562 human leukaemic cells. Br J Cancer (1996) 0.79
Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation. J Exp Clin Cancer Res (2011) 0.78
Bone marrow transplantation for leukaemia. Arch Dis Child (1988) 0.75
Value of colony forming unit-granulocyte macrophage assay in predicting relapse in acute myeloid leukaemia. J Clin Pathol (1996) 0.75
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature (1985) 8.32
Graft-versus-leukemia reactions after bone marrow transplantation. Blood (1990) 7.11
IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol (1997) 4.52
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol (1997) 4.51
Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci U S A (1988) 4.40
Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell (1986) 3.59
Bone marrow transplantation after the Chernobyl nuclear accident. N Engl J Med (1989) 3.46
Cord-blood-cell transplantation--a real sleeper? N Engl J Med (1995) 3.29
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol (1990) 3.19
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol (1998) 3.06
Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood (1994) 2.93
Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med (1993) 2.85
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med (1983) 2.53
HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. Ann Intern Med (1996) 2.52
Clinical uses of intravenous immunoglobulins. Ann Intern Med (1990) 2.29
Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood (1976) 2.29
Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells. Bone Marrow Transplant (2006) 2.29
Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients. Clin Infect Dis (1999) 2.28
T-cell depletion of HLA-identical transplants in leukemia. Blood (1991) 2.25
Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc Natl Acad Sci U S A (1993) 2.12
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood (1993) 2.12
Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia. Ann Intern Med (1980) 2.11
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant (2008) 2.10
Is there a T-cell form of chronic lymphocytic leukemia? Leukemia (1992) 2.08
Allogeneic blood stem cell transplantation: considerations for donors. Blood (1997) 2.03
What's new in blood progenitor cell autotransplants? Bone Marrow Transplant (1994) 1.98
Polymorphonuclear leukocytes in antibody-dependent cellular cytotoxicity. J Immunol (1975) 1.98
Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood (1990) 1.98
Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res (1993) 1.89
A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood (1979) 1.83
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. Bone Marrow Transplant (2011) 1.82
High remission-induction rate in acute myeloid leukaemia. Lancet (1977) 1.78
Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? Blood (1992) 1.77
Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. Science (1987) 1.76
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol (1997) 1.75
Infectious complications of human bone marrow transplantation. Medicine (Baltimore) (1979) 1.74
Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med (1982) 1.74
Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med (1988) 1.73
Outcome after allogeneic bone marrow transplant for leukemia in older adults. JAMA (1993) 1.70
Surface markers on leukemia and lymphoma cells: recent advances. Blood (1982) 1.69
Chronic graft versus host disease: a syndrome of disordered immunity. Am J Med (1979) 1.65
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol (2005) 1.65
Acute lymphoblastic leukemia: recent advances in biology and therapy. Blood (1989) 1.65
Age of onset and type of leukaemia. Lancet (1989) 1.64
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. J Clin Oncol (1998) 1.64
Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients. Leukemia (2002) 1.62
Bone-marrow transplantation for leukaemia. Lancet (1995) 1.60
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood (1999) 1.58
p53 in chronic myelogenous leukemia in acute phase. Proc Natl Acad Sci U S A (1991) 1.56
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant (2004) 1.55
Bone marrow origin of hepatic macrophages (Kupffer cells) in humans. Science (1978) 1.53
An 8-kilobase abl RNA transcript in chronic myelogenous leukemia. Proc Natl Acad Sci U S A (1984) 1.51
Modulation of polymorphonuclear leukocyte-mediated antibody-dependent cellular cytotoxicity. J Immunol (1974) 1.51
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. JAMA (1999) 1.49
Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med (1987) 1.48
Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood (1989) 1.46
Altered transcription of an oncogene in chronic myeloid leukaemia. Lancet (1984) 1.46
The role of T-cells in preventing relapse in chronic myelogenous leukemia. Bone Marrow Transplant (1987) 1.45
Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med (1980) 1.44
Bone marrow transplantation for Fanconi anemia. Blood (1995) 1.42
A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature (1987) 1.42
Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med (1986) 1.42
Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med (1997) 1.41
'A rose by any other name would smell as sweet', or would it? Bone Marrow Transplant (2013) 1.41
Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion (1996) 1.40
How best to analyse new strategies in bone marrow transplantation. Bone Marrow Transplant (1990) 1.39
Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol (2000) 1.36
Immediate medical consequences of nuclear accidents. Lessons from Chernobyl. JAMA (1987) 1.35
Origin of human bone marrow fibroblasts. Br J Haematol (1980) 1.34
Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav Immun (1991) 1.34
Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood (1996) 1.33
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood (2000) 1.33
Ex vivo expansion of umbilical cord blood. Cytotherapy (2005) 1.32
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood (2001) 1.32
Allogeneic bone marrow transplantation for low-grade lymphoma. Blood (1998) 1.29
Impact of complete remission with intensive therapy in patients with responsive multiple myeloma. Bone Marrow Transplant (2001) 1.27
Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science (1984) 1.26
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial. Leukemia (2013) 1.26
MPN-associated myelofibrosis (MPN-MF). Leuk Res (2010) 1.25
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. Bone Marrow Transplant (1998) 1.25
Pneumococcal infections after human bone-marrow transplantation. Ann Intern Med (1979) 1.23
Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Bone Marrow Transplant (1991) 1.23
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. J Clin Oncol (1996) 1.22
Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients. Am J Med (1984) 1.21
Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis (1996) 1.20
Non-myeloablative transplants for malignant disease. Hematology Am Soc Hematol Educ Program (2001) 1.20
bcr genes and transcripts. Oncogene (1988) 1.19
Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood (1992) 1.19
How does bone-marrow transplantation cure leukaemia? Lancet (1984) 1.19
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood (2000) 1.19
Cytomegalovirus immune plasma in bone marrow transplant recipients. Ann Intern Med (1982) 1.18
Chronic lymphocytic leukemia: new insights into biology and therapy. Ann Intern Med (1990) 1.17
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med (1981) 1.17
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Bone Marrow Transplant (2001) 1.16